Investor Relations

News

Month Year

Email Alerts

Chemomab Therapeutics to Participate in H.C. Wainwright Global Investment Conference

May 18, 2022
Chemomab Therapeutics Announces First Quarter 2022 Financial Results and Provides Corporate Update

May 12, 2022
Chemomab Therapeutics to Report First Quarter 2022 Financial Results and Provide a Business Update

May 04, 2022
Chemomab Therapeutics to Participate in Cantor Fitzgerald Rare Orphan Disease Summit

March 23, 2022
Chemomab Reports on Two Scientific Presentations that Support the Potential Therapeutic Utility of CM-101 in Systemic Sclerosis

March 14, 2022
Chemomab Therapeutics to Present at the 32nd Annual Oppenheimer Healthcare Conference

March 10, 2022
Chemomab Therapeutics Announces Fourth Quarter and Year End 2021 Financial Results and Provides a Corporate Update

March 09, 2022

--Company Announces Revisions Intended to Optimize CM-101 Clinical Development Program and Produce More Informative Data, More Rapidly and Efficiently; Changes Also Expected to Extend Cash Runway through End of 2023--
- Photos 1
Chemomab Therapeutics to Report Fourth Quarter and Full Year 2021 Financial Results and Provide a Business Update

March 02, 2022
- Photos 1
Chemomab Therapeutics Names Jack Lawler Vice President of Global Clinical Development Operations

January 04, 2022

- Company Also Announces Move to an Expanded Scientific and Business Facility in Israel
Chemomab to Participate in LifeSci Partners Annual Corporate Access Event and H.C. Wainwright BioConnect 2022 Healthcare Conference

December 20, 2021
- Photos 1

Su	Mo	Tu	We	Th	Fr	Sa

Su	Mo	Tu	We	Th	Fr	Sa